U.S. flag

An official website of the United States government

NM_000518.5(HBB):c.20A>T (p.Glu7Val) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 7, 2014
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000623118.2

Allele description

NM_000518.5(HBB):c.20A>T (p.Glu7Val)

Genes:
LOC106099062:HBB recombination region [Gene]
HBB:hemoglobin subunit beta [Gene - OMIM - HGNC]
LOC107133510:origin of replication at HBB [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_000518.5(HBB):c.20A>T (p.Glu7Val)
Other names:
E6V; HbS
HGVS:
  • NC_000011.10:g.5227002T>A
  • NG_000007.3:g.70614A>T
  • NG_042296.1:g.533T>A
  • NG_046672.1:g.4937T>A
  • NG_059281.1:g.5070A>T
  • NM_000518.5:c.20A>TMANE SELECT
  • NP_000509.1:p.Glu7Val
  • NP_000509.1:p.Glu7Val
  • LRG_1232t1:c.20A>T
  • LRG_1232:g.5070A>T
  • LRG_1232p1:p.Glu7Val
  • NC_000011.9:g.5248232T>A
  • NM_000518.4:c.20A>T
  • P68871:p.Glu7Val
Protein change:
E7V; Glu6Val
Links:
Genetic Testing Registry (GTR): GTR000115629; Genetic Testing Registry (GTR): GTR000500319; UniProtKB: P68871#VAR_002863; OMIM: 141900.0039; OMIM: 141900.0040; OMIM: 141900.0243; OMIM: 141900.0244; OMIM: 141900.0245; OMIM: 141900.0246; OMIM: 141900.0247; OMIM: 141900.0521; OMIM: 141900.0523; dbSNP: rs334
NCBI 1000 Genomes Browser:
rs334
Molecular consequence:
  • NM_000518.5:c.20A>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000741189Ambry Genetics
criteria provided, single submitter

(ambry_reporting_categories_2017)
Pathogenic
(Sep 7, 2014)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1yesclinical testing

Citations

PubMed

Sickle-cell disease.

Rees DC, Williams TN, Gladwin MT.

Lancet. 2010 Dec 11;376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X. Epub 2010 Dec 3. Review.

PubMed [citation]
PMID:
21131035

Beta-thalassemia.

Galanello R, Origa R.

Orphanet J Rare Dis. 2010 May 21;5:11. doi: 10.1186/1750-1172-5-11. Review.

PubMed [citation]
PMID:
20492708
PMCID:
PMC2893117
See all PubMed Citations (7)

Details of each submission

From Ambry Genetics, SCV000741189.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providedyesclinical testing PubMed (7)

Description

Lines of evidence used in support of classification: POSITIVE: Relevant Alteration(s) Detected

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Dec 3, 2022